Bevacizumab/Cetuximab/Irinotecan Regimen

Preferred Label : Bevacizumab/Cetuximab/Irinotecan Regimen;

NCIt synonyms : Bevacizumab Cetuximab Irinotecan; Bevacizumab-Cetuximab-Irinotecan; Bevacizumab/Cetuximab/Irinotecan; Bevacizumab-Cetuximab-Irinotecan Regimen;

NCIt related terms : CBI;

NCIt definition : A regimen consisting of bevacizumab, cetuximab and irinotecan that may be used in the treatment of colorectal cancer.;

Details

Origin ID

C37554;

UMLS CUI

C1328137;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Cetuximab [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database-Regimen [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients